Cantu Syndrome Is Caused by Mutations in ABCC9
Date
2012Author
Gilissen, Christian
Hennekam, Raoul C. M.
Le Merrer, Martine
Wieskamp, Nienke
de Vries, Petra
Steehouwer, Marloes
Veltman, Joris A.
Robertson, Stephen P.
Brunner, Han G.
de Vries, Bert B. A.
Hoischen, Alexander
Eser, Metin
Kayserili, Hulya
van Bon, Bregje W. M.
Grange, Dorothy K.
Engels, Hartmut
Reutter, Heiko
Ostergaard, John R.
Morava, Eva
Tsiakas, Konstantinos
Isidor, Bertrand
Metadata
Show full item recordAbstract
Cantu syndrome is a rare disorder characterized by congenital hypertrichosis, neonatal macrosomia, a distinct osteochondrodysplasia, and cardiomegaly. Using an exome-sequencing approach applied to one proband-parent trio and three unrelated single cases, we identified heterozygous mutations in ABCC9 in all probands. With the inclusion of the remaining cohort of ten individuals with Cantu syndrome, a total of eleven mutations in ABCC9 were found. The de novo occurrence in all six simplex cases in our cohort substantiates the presence of a dominant disease mechanism. All mutations were missense, and several mutations affect Arg1154. This mutation hot spot lies within the second type 1 transmembrane region of this ATP-binding cassette transporter protein, which may suggest an activating mutation. ABCC9 encodes the sulfonylurea receptor (SUR) that forms ATP-sensitive potassium channels (K-ATP channels) originally shown in cardiac, skeletal, and smooth muscle. Previously, loss-of-function mutations in this gene have been associated with idiopathic dilated cardiomyopathy type 10 (CMD10). These findings identify the genetic basis of Cantu syndrome and suggest that this is a new member of the potassium channelopathies.
Collections
- Makale [92796]